| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 6 |
| 1 | ASPIRIN | 5 |
| 2 | ASPIRIN 325 MG | 5 |
| 3 | ASPIRIN 81 MG | 5 |
| 4 | AZILSARTAN KAMEDOXOMIL | 5 |
| 5 | BEVACIZUMAB | 5 |
| 6 | FEBUXOSTAT | 5 |
| 7 | FEBUXOSTAT TABLETS 40 MG | 5 |
| 8 | FEBUXOSTAT TABLETS 80 MG | 5 |
| 9 | IBUPFROFEN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AZILSARTAN KAMEDOXOMIL | 5 | 0.0016 |
| 1 | SOMATROGON-GHLA | 1 | 0.0008 |
| 2 | METRELEPTIN | 1 | 0.0008 |
| 3 | FEBUXOSTAT TABLETS 40 MG | 5 | 0.0005 |
| 4 | TRABECTEDIN | 1 | 0.0004 |
| 5 | PALONOSETRON HYDROCHLORIDE | 2 | 0.0004 |
| 6 | LEVOLEUCOVORIN INJECTION | 1 | 0.0003 |
| 7 | FEBUXOSTAT | 5 | 0.0003 |
| 8 | LEVOLEUCOVORIN | 1 | 0.0003 |
| 9 | VONOPRAZAN FUMARATE | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leptin Analog [EPC] | 1 | 0.0008 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 2 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 4 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 6 | 0.0000 |
| 6 | Iron Chelator [EPC] | 1 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 6 | 0.0000 |
| 9 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |